Late Breakers Session
| Tuesday, November 10, 2026 |
| 4:00 PM - 5:00 PM |
Speaker
Dr Paul MacCartney
Addiction Medicine Specialist
Cohealth
Exploring trauma rates in people seeking opioid dependence treatment in a community setting
4:10 PM - 4:15 PMBiography
Paul is a General Practitioner and Addiction Medicine Specialist, working in Community Health in Fitzroy and Collingwood for the past 26 years. Paul was appointed to the role of Chief Addiction Medicine Advisor to the Victorian Government in 2024 and has a special interest in pharmacotherapy for ODT and alcohol.
Prof Leanne Hides
Deputy Director National Centre For Youth Substance Use Research
The University Of Queensland
Dr Daisy Gibbs
Senior Evaluation Officer
Burnet Institute
It’s Your Right 2: Peer leadership in delivery of hepatitis C harm reduction, testing and treatment
4:20 PM - 4:25 PMBiography
Daisy is a senior evaluation officer with the EC Australia team at Burnet Institute, working predominantly to evaluate health promotion and education programs designed and delivered by community organisations.
Dr Tristan Hurzeler
Postdoctoral Researcher
Univerity of Sydney
Characteristics and treatment needs of Australian adults drinking above national alcohol guidelines
4:25 PM - 4:30 PMBiography
Dr Tristan Hurzeler is a Postdoctoral Researcher at the University of Sydney whose research focuses on understanding the mechanisms underlying alcohol use disorder, developing novel interventions, and advancing personalised medicine. His work integrates clinical trials, treatment mechanisms and data-driven approaches to improve the prevention, assessment, and treatment of alcohol-related harm.
Dr Brendan Quinn
Sexual And Reproductive Health Epidemiologist
Burnet Institute
Higher rates of infectious syphilis test positivity among women in Australia ever prescribed opioid agonist therapy (OAT)
4:30 PM - 4:35 PMBiography
Over a 20-year career in both academia and the public service, Dr Quinn's work has focused primarily on the epidemiology of alcohol and other substance use and related harms, and sexual and reproductive health, especially among underserved populations. He has worked at the Burnet Institute for around 12 years.
Tuan Muhammad Yusuf Jimmy
Peer Counselor
PKNI
Community-led harm reduction response to the transition from smoking to injecting methamphetamine in urban Indonesia
4:35 PM - 4:40 PMBiography
Muhammad Yusuf Jimmy is an addiction counsellor with 20 years of experience in treatment and harm reduction. An active member of the Indonesian Drug Users Network (PKNI), he develops community-led initiatives and advocates for evidence-informed policies that prioritize the meaningful involvement of people with lived drug experiences.
Ms Clare Gorman
Master Of Epidemiology Student
University Of Queensland
Intended risk reduction behaviours following an unexpected result at Queensland's first fixed-site community drug checking service: A retrospective observational analysis
4:40 PM - 4:45 PMBiography
Clare Gorman is a Master of Epidemiology graduate at the University of Queensland and a Medical Affairs Manager for Australia and New Zealand at AbbVie. She has a broader interest in harm reduction and evidence-based drug policy.
Mr Brock Peake
Research Associate
Adelaide University
Drug residue analysis of discarded paraphernalia: 12-month spatio-temporal patterns from South Australia
4:45 PM - 4:50 PMBiography
I am currently a Research Associate within the Population Health Chemistry Group, working in the field of wastewater-based epidemiology.
My current research focuses on novel psychoactive substances (NPS), with a particular emphasis on nitazenes, investigating their presence and trends in wastewater and drug paraphernalia.
Mr Benjamin Bonenti
Research Fellow
University of Queensland
What’s Really in the Glow Stack? Composition of Illicit Injectable Peptides Purchased in Australia
4:50 PM - 4:55 PMBiography
**Dr Timothy Piatkowski** is a Research Fellow in the School of Public Health, Faculty of Health, Medicine, and Behavioural Sciences at The University of Queensland and an NHMRC Emerging Leadership Fellow. His research focuses on alcohol and other drugs, harm reduction, performance and image enhancing drugs, and research into policy.
